All In Biotech

Free tool

FAERS Monitor: Bicillin L-A

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 050141 or its brand name (Bicillin L-A, Penicillin G Benzathine). Reports on generic versions are filed under their own applications.

Reports

1,363

Serious

496

36% of reports

Hospitalization

254

Death reported

39

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • recalled product administered573
  • drug hypersensitivity67
  • injection site pain63
  • off label use45
  • embolia cutis medicamentosa44
  • pain43
  • drug ineffective33
  • acute kidney injury31
  • rash28
  • diarrhoea26
  • no adverse event25
  • headache24
  • injection site swelling23
  • pyrexia23
  • foetal exposure during pregnancy21

Reports by year received

View as table
YearReports
200410
20056
20066
20074
200817
20098
201051
201124
201224
201313
201410
201520
201630
201736
201834
201986
202068
202139
202288
202362
202462
2025622
202643

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,796 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
recalled product administeredSignal573986.2923.5529,435
embolia cutis medicamentosaSignal44903.8670.036,637
drug hypersensitivitySignal675.34.2234
injection site swellingSignal234.63.162
foetal exposure during pregnancySignal214.02.644
injection site painSignal633.22.593
acute kidney injurySignal313.12.243
no adverse eventSignal252.11.414
pain431.10.80
pyrexia231.00.70
rash281.00.70
off label use450.80.62
diarrhoea260.60.46
headache240.60.47
drug ineffective330.40.334

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.